These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1622128

  • 41. [Induction of manganese superoxide dismutase in ovarian carcinoma].
    Ishikawa M, Nakata T, Shimizu T, Taniguchi N.
    Rinsho Byori; 1992 Apr; 40(4):359-62. PubMed ID: 1593761
    [Abstract] [Full Text] [Related]

  • 42. Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.
    Jeschke U, Wiest I, Schumacher AL, Kupka M, Rack B, Stahn R, Karsten U, Mayr D, Friese K, Dian D.
    Anticancer Res; 2012 May; 32(5):2185-9. PubMed ID: 22593508
    [Abstract] [Full Text] [Related]

  • 43. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
    Kawai M, Yamashita H, Hayashi T, Kamiya N, Kakihara M, Arii Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):402-10. PubMed ID: 3457877
    [Abstract] [Full Text] [Related]

  • 44. Tumor markers.
    Seleznick MJ.
    Prim Care; 1992 Dec; 19(4):715-26. PubMed ID: 1281552
    [Abstract] [Full Text] [Related]

  • 45. [Study of the mechanism of tumor marker CA125 in serum].
    Kiyozuka Y, Noda T, Adachi S, Adachi S, Akada S, Ichijo M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1951-8. PubMed ID: 2592818
    [Abstract] [Full Text] [Related]

  • 46. [Clinical significance of manganese superoxide dismutase in ovarian carcinoma].
    Ishikawa M, Hayashi H, Saitoh S, Shimizu T, Yamashita K, Saitoh Y, Kanemoto T, Domon H, Kamiya H, Endoh Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):509-15. PubMed ID: 2056226
    [Abstract] [Full Text] [Related]

  • 47. [Development and clinical research of computer aided multivariate pattern analysis system (CAMPAS) OV-1 for diagnosis of ovarian carcinoma].
    Kobayashi S, Murae M, Kimura E.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):241-8. PubMed ID: 8492011
    [Abstract] [Full Text] [Related]

  • 48. [Applications of tumor markers to the screening of endometrial and ovarian cancers].
    Nozawa S, Takamatsu K, Tsukazaki K, Udagawa Y.
    Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma].
    Nozawa S, Kiguchi K, Yajima M, Udagawa Y, Sakuma T, Iizuka R, Narisawa S, Sakayori M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259
    [Abstract] [Full Text] [Related]

  • 51. [Current advancement of assay of tumor markers and the perspective in future].
    Kawamura T.
    Nihon Rinsho; 1996 Jun; 54(6):1642-8. PubMed ID: 8691623
    [Abstract] [Full Text] [Related]

  • 52. Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy.
    Zhou M, Guan W, Walker LD, Mezencev R, Benigno BB, Gray A, Fernández FM, McDonald JF.
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2262-71. PubMed ID: 20699376
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546.
    Saito M, Aoki D, Susumu N, Suzuki A, Suzuki N, Udagawa Y, Nozawa S.
    Int J Gynecol Cancer; 2005 Sep; 15(1):37-44. PubMed ID: 15670295
    [Abstract] [Full Text] [Related]

  • 59. Advanced ovarian cancer. Tumour markers.
    Rustin GJ, van der Burg ME, Berek JS.
    Ann Oncol; 1993 Sep; 4 Suppl 4():71-7. PubMed ID: 8312203
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.